Even the strongest science does not guarantee an investable asset. Here, we discuss how to align early-stage discovery programs for small molecules with investor expectations in a complex biotech funding environment.
Digital-first healthcare provider honored by Newsweek and Statista as a top innovator in virtual primary, urgent, behavioral care, genomics, and at-home testing—solidifying its leadership in telehealth.
Recuro Health, a Dallas-based digital health startup, raised $47 M to scale its Digital Medical Home—including virtual primary & behavioral care, at-home diagnostics, and genomics—with support from ARCH Venture Partners and others.
.avif)
Health‑IT platform ‘connecting the connective tissue for healthcare’ closes a $40 M financing round and partners with Elation Health to integrate its ZAP aggregated patient profile into primary‑care EHR workflows.
.avif)
A trailblazing MIT professor and co‑founder of Moderna who pioneered nanoparticle delivery of nucleic acids. Despite early skepticism and patent rejections, his persistence led to breakthroughs foundational for mRNA vaccines.
Join us in building the future of medicine through innovative technology and biology convergence